S
MRNA icon

swisspartners’s Moderna MRNA Stock Holding History

swisspartners’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$1.01M Hold
5,600
– – 1.28% 28
2022
Q3 		$662K Sell
5,600
-1,300
-19% -$197K 0.69% 38
2022
Q2 		$1.02M Sell
6,900
-1,750
-20% -$250K 0.97% 28
2022
Q1 		$1.49M Buy
8,650
+2,250
+35% +$379K 1.18% 27
2021
Q4 		$1.65M Buy
6,400
+800
+14% +$234K 1.17% 27
2021
Q3 		$2.15M Sell
5,600
-400
-7% -$148K 1.67% 18
2021
Q2 		$1.41M Sell
6,000
-330
-5% -$59K 1% 31
2021
Q1 		$830K Sell
6,330
-1,670
-21% -$242K 0.67% 38
2020
Q4 		$822K Buy
+8,000
New +$809K 0.72% 39

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

swisspartners's MRNA Position: Q4 2022 in Review

swisspartners held its Moderna (MRNA) position steady in Q4 2022 at 5,600 shares worth $1.01M. The position accounts for 1.28% of the portfolio, ranked #28.

swisspartners first reported a position in MRNA in Q4 2020 and has held it in 9 quarters since. The position peaked at $2.15M in Q3 2021. 1,071 funds tracked by Wall St. Rank hold MRNA as of Q4 2022.

  • swisspartners held 5,600 shares of Moderna worth $1.01M as of Q4 2022.
  • swisspartners left its Moderna share count unchanged in Q4 2022.
  • Moderna made up 1.28% of swisspartners's portfolio in Q4 2022, its #28 holding.
  • swisspartners first reported a position in Moderna in Q4 2020 and has held it in 9 quarters since.
  • swisspartners's Moderna position peaked at $2.15M in Q3 2021.
  • 1,071 funds tracked by Wall St. Rank held Moderna as of Q4 2022.

Based on swisspartners's 13F filing for Q4 2022, filed 14 Feb 2023.